These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11214790)

  • 1. Candesartan and acute liver injury.
    González-Jiménez D; Varela JM; Calderón E; Galindo J; González de la Puente MA
    Eur J Clin Pharmacol; 2000 Dec; 56(9-10):769-70. PubMed ID: 11214790
    [No Abstract]   [Full Text] [Related]  

  • 2. [Acute hepatitis induced by candesartan].
    Vallejo I; García Morillo S; Pamies E
    Med Clin (Barc); 2000 Nov; 115(18):719. PubMed ID: 11141435
    [No Abstract]   [Full Text] [Related]  

  • 3. Candesartan cilexetil vs losartan.
    Bunt T
    Blood Press; 1998 Jul; 7(4):251-2. PubMed ID: 9858118
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of dual blockade of the renin-angiotensin system in primary proteinuric nephropathies.
    Luño J; Barrio V; Goicoechea MA; González C; de Vinuesa SG; Gómez F; Bernis C; Espinosa M; Ahijado F; Gómez J; Escalada P
    Kidney Int Suppl; 2002 Dec; (82):S47-52. PubMed ID: 12410855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive effects of candesartan cilexetil, enalapril and placebo.
    Franke H
    J Hum Hypertens; 1997 Sep; 11 Suppl 2():S61-2. PubMed ID: 9331010
    [No Abstract]   [Full Text] [Related]  

  • 6. Candesartan for hypertension.
    Med Lett Drugs Ther; 1998 Nov; 40(1040):109-10. PubMed ID: 9844624
    [No Abstract]   [Full Text] [Related]  

  • 7. Angiotensin receptor antagonists.
    Wong W; Howes L
    Aust Fam Physician; 2000 Jul; 29(7):653-5, 658. PubMed ID: 10914449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Candesartan cilexetil and enalapril are of equivalent efficacy in patients with mild to moderate hypertension.
    Zanchetti A; Omboni S; Di Biagio C
    J Hum Hypertens; 1997 Sep; 11 Suppl 2():S57-9. PubMed ID: 9331009
    [No Abstract]   [Full Text] [Related]  

  • 9. [Change from ACE inhibitor, Ca-antagonist or beta-blocker to candesartan cilexetil: better efficacy and tolerance. SWITCH study (German study segment)].
    Baumgart P; Reismann J; Pohlmeyer H; Düsing R
    Dtsch Med Wochenschr; 2001 May; 126(19):547-50. PubMed ID: 11402910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perindopril and candesartan comparative efficacy and safety in type II diabetic hypertensive patients.
    Derosa G; Cicero AF; Mugellini A; Ciccarelli L; Fogari R
    J Hum Hypertens; 2003 Jun; 17(6):433-5. PubMed ID: 12764407
    [No Abstract]   [Full Text] [Related]  

  • 11. [Angiotensin II antagonist treatment as a contributory cause of acute renal failure].
    Nielsen LR
    Ugeskr Laeger; 2003 Mar; 165(13):1368-9. PubMed ID: 12703286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized trial of candesartan cilexetil in the treatment of patients with congestive heart failure and a history of intolerance to angiotensin-converting enzyme inhibitors.
    Granger CB; Ertl G; Kuch J; Maggioni AP; McMurray J; Rouleau JL; Stevenson LW; Swedberg K; Young J; Yusuf S; Califf RM; Bart BA; Held P; Michelson EL; Sellers MA; Ohlin G; Sparapani R; Pfeffer MA
    Am Heart J; 2000 Apr; 139(4):609-17. PubMed ID: 10740141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preferences in general practice. Interview by Christine Vetter].
    Holzgreve H
    Fortschr Med; 1998 May; 116(13):44-5. PubMed ID: 9630784
    [No Abstract]   [Full Text] [Related]  

  • 14. A Randomized, Double-blind, Candesartan-controlled, Parallel Group Comparison Clinical Trial to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan in Patients with Mild to Moderate Essential Hypertension.
    Lee JH; Yang DH; Hwang JY; Hur SH; Cha TJ; Kim KS; Kim MH; Chun KJ; Cha GS; Hong GR; Lee SG; Kim DS; Kim DI; Chae SC
    Clin Ther; 2016 Jun; 38(6):1485-1497. PubMed ID: 27161546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angioedema associated with candesartan.
    Lo KS
    Pharmacotherapy; 2002 Sep; 22(9):1176-9. PubMed ID: 12222554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Candesartan in the treatment of hypertension: what have we learnt in the last decade?
    Barrios V; Escobar C
    Expert Opin Drug Saf; 2011 Nov; 10(6):957-68. PubMed ID: 21848481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicentre, 12-week study of imidapril and candesartan cilexetil in patients with mild to moderate hypertension using ambulatory blood pressure monitoring.
    Palma-Gamiz JL; Pêgo M; Marquez E; Pujol M; Olivan J; Alegría E; Sagastagoitia-Gorostiza JD; Gonzalez-Juanatey JR
    Clin Drug Investig; 2007; 27(6):407-17. PubMed ID: 17506591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noncholestatic acute hepatocellular injury following candesartan administration.
    Lammel-Lindemann JA; Flores-Villalba E; Martagón AJ; DeObeso-Gonzalez E; Puente-Gallegos F
    Br J Clin Pharmacol; 2018 Jan; 84(1):204-207. PubMed ID: 28841231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Warnings against candesartan in pregnancy are not implemented in physicians' practice.
    Borthen C; Oglaend B; Eggebøe T; Ellingsen CL; Schjøtt J
    Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):235. PubMed ID: 19615811
    [No Abstract]   [Full Text] [Related]  

  • 20. Rash and acute nephritic syndrome due to candesartan.
    Morton A; Muir J; Lim D
    BMJ; 2004 Jan; 328(7430):25. PubMed ID: 14703542
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.